These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 24391813)

  • 1. Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.
    McDermott AM; Kerin MJ; Miller N
    PLoS One; 2013; 8(12):e83718. PubMed ID: 24391813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
    McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ
    PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.
    Eriksen AH; Andersen RF; Pallisgaard N; Sørensen FB; Jakobsen A; Hansen TF
    PLoS One; 2016; 11(3):e0150593. PubMed ID: 26937645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer.
    Davoren PA; McNeill RE; Lowery AJ; Kerin MJ; Miller N
    BMC Mol Biol; 2008 Aug; 9():76. PubMed ID: 18718003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of suitable endogenous control genes for microRNA expression profiling of childhood medulloblastoma and human neural stem cells.
    Genovesi LA; Anderson D; Carter KW; Giles KM; Dallas PB
    BMC Res Notes; 2012 Sep; 5():507. PubMed ID: 22980291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
    PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
    Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.
    Bignotti E; Calza S; Tassi RA; Zanotti L; Bandiera E; Sartori E; Odicino FE; Ravaggi A; Todeschini P; Romani C
    J Cell Mol Med; 2016 Dec; 20(12):2341-2348. PubMed ID: 27419385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer.
    Chang KH; Mestdagh P; Vandesompele J; Kerin MJ; Miller N
    BMC Cancer; 2010 Apr; 10():173. PubMed ID: 20429937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of microRNAs as endogenous controls for quantitative polymerase chain reaction in plasma for stable coronary artery disease.
    Zhang Y; Tang W; Peng L; Tang J; Yuan Z
    Cardiol J; 2016; 23(6):694-703. PubMed ID: 27976798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
    Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
    Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer.
    McNeill RE; Miller N; Kerin MJ
    BMC Mol Biol; 2007 Nov; 8():107. PubMed ID: 18042273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying MiR-140-3p as a stable internal reference to normalize MicroRNA qRT-PCR levels of plasma small extracellular vesicles in lung cancer patients.
    Jiang Y; Wang W; Tang F; Zhang W; Chen S; Gu X; Chen P; Xu X; Nian B; Li Z; Chen C; Yin H; Su L; Sun H; Chen W; Zhang D; Li Y
    Genomics; 2024 Jul; 116(4):110875. PubMed ID: 38849018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
    Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
    Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.
    Zhang K; Zhao S; Wang Q; Yang HS; Zhu J; Ma R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S536-44. PubMed ID: 25976861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNA-based screening tool for breast cancer.
    Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
    Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.